Murillo L. Martins

Probing the dynamics of complexed local anesthetics via neutron scattering spectroscopy and DFT calculations

Since potential changes in the dynamics and mobility of drugs upon complexation for delivery may affect their ultimate efficacy, we have investigated the dynamics of two local anesthetic molecules, bupivacaine (BVC, C18H28N2O) and ropivacaine (RVC, C17H26N2O), in both their crystalline forms and complexed with water-soluble oligosaccharide 2-hydroxypropyl-β-cyclodextrin (HP-β-CD). The study was carried out by neutron scattering spectroscopy, along with thermal analysis, and density functional theory computation. Mean square displacements suggest that RVC may be less flexible in crystalline form than BVC, but both molecules exhibit very similar dynamics when confined in HP-β-CD. The use of vibrational analysis by density functional theory (DFT) made possible the identification of molecular modes that are most affected in both molecules by insertion into HP-β-CD, namely those of the piperidine rings and methyl groups. Nonetheless, the somewhat greater structure in the vibrational spectrum at room temperature of complexed RVC than that of BVC, suggests that the effects of complexation are more severe for the latter. This unique approach to the molecular level study of encapsulated drugs should lead to deeper understanding of their mobility and the respective release dynamics.

Restricted mobility of specific functional groups reduces anti-cancer drug activity in healthy cells.

The most common cancer treatments currently available are radio- and chemo-therapy. These therapies have, however, drawbacks, such as, the reduction in quality of life and the low efficiency of radiotherapy in cases of multiple metastases. To lessen these effects, we have encapsulated an anti-cancer drug into a biocompatible matrix. In-vitro assays indicate that this bio-nanocomposite is able to interact and cause morphological changes in cancer cells. Meanwhile, no alterations were observed in monocytes and fibroblasts, indicating that this system might carry the drug in living organisms with reduced clearance rate and toxicity. X-rays and neutrons were used to investigate the carrier structure, as well as to assess the drug mobility within the bio-nanocomposite. From these unique data we show that partial mobility restriction of active groups of the drug molecule suggests why this carrier design is potentially safer to healthy cells.

Enhancing the versatility of alternate current biosusceptometry (ACB) through the synthesis of a dextrose-modified tracer and a magnetic muco-adhesive cellulose gel

Alternate Current Biosusceptometry (ACB) is a promising bio-magnetic method, radiation free and easily performed used for gastric emptying exams. Due to development on its sensitivity level, interesting nature, noninvasiveness and low cost it has attracted a lot of attention. In this work, magnetic nanoparticles of Mn-Zn ferrite as well as dextrose-modified nanoparticles were synthesized to be used as possible tracers in ACB gastric emptying exams. In addition, a magnetic muco-adhesive gel was obtained by modifying the ferrite nanoparticles with cellulose. Based on in-vivo tests in rats, we show that the pure ferrite nanoparticles, whose isoelectric point was found to be at pH=3.2, present a great sensitivity to pH variations along the gastrointestinal tract, while the reduction of the isoelectric point by the dextrose modification leads to suitable nanoparticles for rapid gastric emptying examinations. On the other hand, the in-vivo tests show that the muco-adhesive cellulose gel presents substantial stomach adhesion and is a potential drug delivery system easily traceable by the ACB system.

Encapsulation effects on the structure-dynamics on drug carriers revealed by neutron scattering

Universidade Estadual Paulista Julio de Mesquita Filho, Departamento de Quimica, Instituto de Biociencias, Botucatu, Distrito de Rubiao Junior, Rubiao Junior, CEP 18618000, SP, Brasil

Size-Strain Analysis of Iron-Excess Mn–Zn Ferrite Nanoparticles Using Synchrotron Diffraction and Its Correlation with Magnetic Saturation and Isoelectric pH

Iron-excess Mn-Zn ferrite nanoparticles were prepared by coprecipitation with sodium hydroxide (NaOH) at different concentrations (0.1, 0.2, 0.5 and 1.0 mol/L). The results of X-ray diffraction (XRD) analysis using Whole Powder Pattern Modeling (WPPM) showed that higher concentrations of NaOH promote crystallite growth and broader dispersion in crystallite sizes. Energy dispersive X-ray spectroscopy indicates that zinc loss is noticeable when [NaOH] ≥ 0.2 mol/L. XRD revealed also a significant less-crystalline phase contribution alongside the main peaks of the nanocrystalline cubic spinel ferrite phase. The less-crystalline fraction is lower for the ferrite obtained with 0.2 mol/L of NaOH, being about 50% and more than 70% for the other samples. Despite of the less-crystalline fraction and the excess of iron, no secondary phases were detected. The Warren curves showed that the concentration of NaOH significantly influences the microstrain in the crystallites, being smaller for the sample obtained with NaOH at 0.2 mol/L. The sample prepared with this condition presented the better properties to be used as magnetic tracer in clinical diagnoses combining small mean crystallite size, low microstrain, which resulted in materials with higher magnetic saturation and high surface charge under blood pH.

Raman and Infrared spectroscopies and X-ray diffraction data on bupivacaine and ropivacaine complexed with 2-hydroxypropyl−β−cyclodextrin

The data presented in this article are related to the research article entitled “Probing the dynamics of complexed local anesthetics via neutron scattering spectroscopy and DFT calculations (http://dx.doi.org/10.1016/j.ijpharm.2017.03.051)” (Martins et al., 2017) [1]. This work shows the molecular and structural behavior of the local anesthetics (LAs) bupivacaine (BVC, C18H28N2O) and ropivacaine (RVC, C17H26N2O) before and after complexation with the water-soluble oligosaccharide 2-hydroxypropyl−β−cyclodextrin (HP-β-CD).